ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 284,91
-0,71%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Ironwood Pharmaceuticals Inc (IRWD)

  7. Ironwood Pharmaceuticals Inc (IRWD) Actualités

IRWD Ironwood Pharmaceuticals Inc

7,85
-0,23 (-2,85%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Ironwood Pharmaceuticals Inc IRWD NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,23 -2,85% 7,85 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
8,09 7,77 8,17 7,82 8,08
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202422:01BWIronwood Pharmaceuticals to Host First Quarter 2024 Investor..
28/3/202412:30BWIronwood Pharmaceuticals Announces Positive Results from its..
08/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202412:00BWIronwood Pharmaceuticals Announces Positive Topline Results..
23/2/202413:30BWIronwood Pharmaceuticals to Present Four Abstracts at the..
15/2/202413:04EDGAR2Form 8-K - Current report
15/2/202413:00BWIronwood Pharmaceuticals Reports Fourth Quarter and Full..
15/2/202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:13EDGAR2Form 144 - Report of proposed sale of securities
09/2/202422:11EDGAR2Form 144 - Report of proposed sale of securities
09/2/202422:09EDGAR2Form 144 - Report of proposed sale of securities
09/2/202422:05EDGAR2Form 144 - Report of proposed sale of securities
01/2/202422:01BWIronwood Pharmaceuticals to Host Fourth Quarter and Full..
19/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202401:00BWIronwood Announces Publication in The Lancet..
08/1/202412:05EDGAR2Form 8-K - Current report
08/1/202412:00BWIronwood Pharmaceuticals Maintains FY 2023 Financial..
03/1/202422:01BWIronwood Pharmaceuticals to Present at the 42nd Annual J.P...
19/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202322:26EDGAR2Form 144 - Report of proposed sale of securities
12/12/202322:01BWIronwood Announces the Completion of Squeeze-Out Merger With..
21/11/202322:01BWIronwood Pharmaceuticals to Participate in the Piper Sandler..
20/11/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202322:05EDGAR2Form 144 - Report of proposed sale of securities
09/11/202322:08EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/11/202322:07EDGAR2Form S-3ASR - Automatic shelf registration statement of..
09/11/202313:07EDGAR2Form 8-K - Current report
09/11/202313:00BWIronwood Pharmaceuticals Reports Third Quarter 2023 Results
26/10/202322:01BWIronwood Pharmaceuticals to Host Third Quarter 2023 Investor..
23/10/202313:30BWIronwood Releases New IBS-C and CIC Data at the American..
16/10/202312:00BWIronwood Pharmaceuticals Presents Positive Final Data from..
05/10/202313:30BWIronwood to Present New Data at NASPGHAN Annual Meeting..
19/9/202323:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202323:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202322:30EDGAR2Form 8-K/A - Current report: [Amend]
31/8/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
IRWD
Ironwood Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés